Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
I’ve been reminding myself of the secondary endpoints. Two that interest me will be CVD mortality and total mortality. It’s not impossible that a drug like apabetalone with multiple potentially beneficial metabolic effects in diabetics could lower one or the other mortalities without reducing the primary endpoint. That would a big one. Do we know what the total number of deaths was in the combined groups?
